Desmethylselegiline

Desmethylselegiline

Chemical structure of Desmethylselegiline

Desmethylselegiline, also known as N-desmethylselegiline, is a chemical compound that is a metabolite of the drug selegiline. It is primarily known for its role in the pharmacological effects of selegiline, which is used in the treatment of Parkinson's disease and major depressive disorder.

Chemical Properties

Desmethylselegiline is a derivative of selegiline, characterized by the removal of a methyl group from the nitrogen atom in the propargylamine moiety of selegiline. This structural modification results in a compound with distinct pharmacological properties.

Pharmacology

Desmethylselegiline is an active metabolite of selegiline, contributing to its therapeutic effects. It functions primarily as a selective and irreversible monoamine oxidase B (MAO-B) inhibitor. By inhibiting MAO-B, desmethylselegiline increases the levels of dopamine in the brain, which is beneficial in the management of Parkinson's disease symptoms.

Mechanism of Action

The inhibition of MAO-B by desmethylselegiline prevents the breakdown of dopamine, thereby enhancing dopaminergic activity. This mechanism is crucial in neurodegenerative conditions where dopamine levels are depleted.

Clinical Significance

Desmethylselegiline, as a metabolite of selegiline, plays a significant role in the drug's efficacy and safety profile. The presence of this metabolite contributes to the prolonged action of selegiline, allowing for once-daily dosing in clinical practice.

Therapeutic Uses

While desmethylselegiline itself is not used as a standalone therapeutic agent, its formation in the body is essential for the full therapeutic effect of selegiline in treating Parkinson's disease and depression.

Metabolism

Selegiline is metabolized in the liver to desmethylselegiline and other metabolites, including l-methamphetamine and l-amphetamine. The formation of desmethylselegiline is a key step in the metabolic pathway, influencing the drug's pharmacokinetics and pharmacodynamics.

3D molecular structure of Desmethylselegiline

Safety and Side Effects

The safety profile of desmethylselegiline is closely linked to that of selegiline. Common side effects associated with selegiline, and by extension its metabolites, include nausea, dizziness, and insomnia. The risk of hypertensive crisis, a concern with non-selective MAO inhibitors, is significantly reduced with selective MAO-B inhibitors like desmethylselegiline.

Related Pages

• Selegiline
• Monoamine oxidase inhibitor
• Parkinson's disease
• Dopamine

This article is a stub related to pharmacology. You can help WikiMD by expanding it!